J.P. Morgan has released a research report noting that major state-owned insurers have unveiled capital replenishment plans, including the Ministry of Finance injecting RMB 35 billion and RMB 7 billion into China Life Group and China Taiping Group respectively, as well as subscribing to up to RMB 15 billion in private placement A-shares of PICC GROUP (01339). While the news appears surprising on the surface, the structure is more reassuring, as the funds are primarily directed into the parent group level rather than requiring listed insurers such as CHINA LIFE (02628) to seek refinancing from the market. The potential equity raising by PICC GROUP is also largely confined to its A-share listed entity, which helps alleviate immediate dilution concerns for listed insurers.

The bank stated that capital deployment is not necessarily positive, as it could raise questions about solvency, regulatory pressure, and future shareholder returns. However, support at the group level helps state-owned insurers maintain more stable equity allocations, supports dividend growth, and strengthens their role in industry consolidation. Solvency ratios remain adequate, although the pace of increasing equity allocation weights for insurers is expected to slow by the second quarter of 2026, indicating reduced room for further stock market exposure. Incremental capital at the state-owned group level helps preserve short-term flexibility in asset allocation while safeguarding solvency.

The bank recommends buying CHINA LIFE H-shares on weakness, as they currently trade at 5 times forward 2027 price-to-earnings ratio with a 4% dividend yield. Additionally, PING AN (02318) offers a dividend yield of 7% and may deliver more outstanding performance.